DNLI
Price
$14.69
Change
-$0.21 (-1.41%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
2.13B
28 days until earnings call
TIL
Price
$27.50
Change
+$3.69 (+15.50%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
180.4M
Interact to see
Advertisement

DNLI vs TIL

Header iconDNLI vs TIL Comparison
Open Charts DNLI vs TILBanner chart's image
Denali Therapeutics
Price$14.69
Change-$0.21 (-1.41%)
Volume$115.79K
Capitalization2.13B
Instil Bio
Price$27.50
Change+$3.69 (+15.50%)
Volume$4.38K
Capitalization180.4M
DNLI vs TIL Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. TIL commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongBuy and TIL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (DNLI: $14.69 vs. TIL: $27.50)
Brand notoriety: DNLI and TIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 42% vs. TIL: 172%
Market capitalization -- DNLI: $2.13B vs. TIL: $180.4M
DNLI [@Biotechnology] is valued at $2.13B. TIL’s [@Biotechnology] market capitalization is $180.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileTIL’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • TIL’s FA Score: 1 green, 4 red.
According to our system of comparison, TIL is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while TIL’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 4 bearish.
  • TIL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both DNLI and TIL are a good buy in the short-term.

Price Growth

DNLI (@Biotechnology) experienced а +1.38% price change this week, while TIL (@Biotechnology) price change was +24.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

TIL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.13B) has a higher market cap than TIL($180M). TIL YTD gains are higher at: 44.054 vs. DNLI (-27.920). TIL has higher annual earnings (EBITDA): -67.77M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. TIL (104M). DNLI has less debt than TIL: DNLI (48.6M) vs TIL (86.7M). DNLI (0) and TIL (0) have equivalent revenues.
DNLITILDNLI / TIL
Capitalization2.13B180M1,186%
EBITDA-505.16M-67.77M745%
Gain YTD-27.92044.054-63%
P/E RatioN/AN/A-
Revenue00-
Total Cash818M104M787%
Total Debt48.6M86.7M56%
FUNDAMENTALS RATINGS
DNLI vs TIL: Fundamental Ratings
DNLI
TIL
OUTLOOK RATING
1..100
5769
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
6341
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TIL's Valuation (21) in the Precious Metals industry is significantly better than the same rating for DNLI (93) in the Biotechnology industry. This means that TIL’s stock grew significantly faster than DNLI’s over the last 12 months.

TIL's Profit vs Risk Rating (93) in the Precious Metals industry is in the same range as DNLI (100) in the Biotechnology industry. This means that TIL’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's SMR Rating (94) in the Biotechnology industry is in the same range as TIL (96) in the Precious Metals industry. This means that DNLI’s stock grew similarly to TIL’s over the last 12 months.

TIL's Price Growth Rating (41) in the Precious Metals industry is in the same range as DNLI (63) in the Biotechnology industry. This means that TIL’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's P/E Growth Rating (99) in the Biotechnology industry is in the same range as TIL (100) in the Precious Metals industry. This means that DNLI’s stock grew similarly to TIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLITIL
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IILGX29.830.16
+0.54%
Thrivent Global Stock S
DWUSX17.290.07
+0.41%
DFA World ex US Targeted Val Instl
WFLVX15.46N/A
N/A
Allspring Large Company Value C
MSVZX9.43N/A
N/A
MassMutual Small Company Val I
BTMGX18.43N/A
N/A
iShares MSCI EAFE Intl Idx G